uric acid and tiazofurin

uric acid has been researched along with tiazofurin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (80.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eble, JN; Hoffman, R; Jayaram, HN; Nagai, M; Natsumeda, Y; Paulik, E; Tricot, G; Weber, G; Zhen, WN	1
Weber, G	1
Culham, CA; Hartshorn, JN; Haugh, LD; Krakoff, IR; McCormack, JJ; Newman, RA; Roberts, JD; Stewart, JA; Young, JA	1
Boldt, DH; Clark, GM; Hersh, MR; Kuhn, JG; Melink, TJ; Patton, TF; Siegler, R; Sternson, LA; Von Hoff, DD	1
Cooney, DA; Davignon, JP; Davis, RD; Jayaram, HN; Johns, DG; Malspeis, L; Marsoni, S; O'Dwyer, PJ; Plowman, J; Shoemaker, DD	1

Reviews

1 review(s) available for uric acid and tiazofurin

Article	Year
Tiazofurin: a new antitumor agent. Investigational new drugs, 1984, Volume: 2, Issue:1 Topics: Animals; Antineoplastic Agents; Humans; Mice; Ribavirin; Ribonucleosides; Uric Acid	1984

Trials

1 trial(s) available for uric acid and tiazofurin

Article	Year
Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient. Cancer communications, 1991, Volume: 3, Issue:3 Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Blast Crisis; Blotting, Northern; Down-Regulation; Gene Expression Regulation; Genes, ras; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Ribavirin; RNA; Uric Acid	1991

Article

Year

Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.

Cancer communications, 1991, Volume: 3, Issue:3

Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Blast Crisis; Blotting, Northern; Down-Regulation; Gene Expression Regulation; Genes, ras; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Ribavirin; RNA; Uric Acid

1991

Other Studies

3 other study(ies) available for uric acid and tiazofurin

Article	Year
Critical issues in chemotherapy with tiazofurin. Advances in enzyme regulation, 1989, Volume: 29 Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Down-Regulation; Drug Interactions; Female; Genes, ras; Guanine; Humans; Hypoxanthine; Hypoxanthines; Leukemia; Liver Neoplasms, Experimental; Male; Middle Aged; Ribavirin; Ribonucleosides; Tretinoin; Tumor Cells, Cultured; Uric Acid	1989
Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluation. Cancer treatment reports, 1987, Volume: 71, Issue:2 Topics: Adult; Aged; Allopurinol; Antimetabolites, Antineoplastic; Creatine Kinase; Drug Administration Schedule; Drug Evaluation; Female; Headache; Hemoglobins; Humans; Hypoxanthines; Isoenzymes; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Purines; Ribavirin; Ribonucleosides; Uric Acid; Xanthine; Xanthines	1987
Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193). Cancer research, 1985, Volume: 45, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Aspartate Aminotransferases; Bone Marrow; Creatine Kinase; Drug Evaluation; Female; Humans; Kinetics; Lymphocytes; Male; Middle Aged; Neoplasms; Ribavirin; Ribonucleosides; Uric Acid	1985